You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Triplet

Showing 1 - 25 of 375
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urothelial Carcinoma, Metastatic Cancer Trial in Houston (Pemetrexed, Zimberelimab, Etrumadenant)

Not yet recruiting
  • Urothelial Carcinoma
  • Metastatic Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Nov 28, 2022

Leukemia Trial in Houston (Pirtobrutinib, Obinutuzumab, Venetoclax)

Not yet recruiting
  • Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Sep 7, 2022

Metastatic Colorectal Cancer Trial in Cairo (FOLFOXIRI Protocol)

Completed
  • Metastatic Colorectal Cancer
  • FOLFOXIRI Protocol
  • Cairo, El Manial, Egypt
    Kasr El AiniH
Mar 30, 2022

Recurrent/Advanced Gastric Cancer Trial in Seoul (Chemotherapy)

Not yet recruiting
  • Recurrent/Advanced Gastric Cancer
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Aug 22, 2022

Intrahepatic Cholangiocarcinoma Trial in Fairfax (Induction Chemotherapy Triplet Therapy, Concurrent Y-90 treatment,

Not yet recruiting
  • Intrahepatic Cholangiocarcinoma
  • Induction Chemotherapy Triplet Therapy
  • +2 more
  • Fairfax, Virginia
    Inova Schar Cancer Institute
Jun 14, 2022

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Refractory Cutaneous Melanoma Trial in Portland (Ipilimumab, Nivolumab, Cabozantinib)

Recruiting
  • Refractory Cutaneous Melanoma
  • Portland, Oregon
    Providence Portland Medical Center
Jun 8, 2022

Myeloid Malignancy, MDS, Myelofibrosis Trial in Boston (Navitoclax, Venetoclax, Decitabine)

Recruiting
  • Myeloid Malignancy
  • +4 more
  • Boston, Massachusetts
  • +2 more
Jul 21, 2022

Locally Advanced Rectal Carcinoma, Stage II Rectal Cancer AJCC v8, Stage III Rectal Cancer AJCC v8 Trial in Gainesville, New

Recruiting
  • Locally Advanced Rectal Carcinoma
  • +2 more
  • Gainesville, Florida
  • +1 more
Jan 4, 2023

Locally Advanced Rectal Cancer Trial in Pisa (drug, radiation, procedure)

Recruiting
  • Locally Advanced Rectal Cancer
  • Pisa, Italy
    U.O. Oncologia Medica 2 Universitaria - Azienda Ospedaliero-Univ
Mar 9, 2022

Locally Advanced Rectal Cancer Trial in Beijing (FOLFOXIRI)

Completed
  • Locally Advanced Rectal Cancer
  • Beijing, China
    National Cancer Center/Cancer Hospital, Chinese ACademy of Medic
Jan 29, 2021

Unresectable Hepatocellular Carcinoma, Hepatocellular Carcinoma by BCLC Stage Trial in Guangzhou, Guanzhou, Changsha (Hepatic

Recruiting
  • Unresectable Hepatocellular Carcinoma
  • Hepatocellular Carcinoma by BCLC Stage
  • Hepatic Arterial Infusion(mFOLFOX7) combined with Bevacizumab and Sintilimab
  • Guangzhou, Guangdong, China
  • +4 more
May 4, 2022

Resectable Gastric and Gastroesophageal Junction Adenocarcinoma Trial in Norway, Sweden (Fluorouracil, Oxaliplatin, Irinotecan)

Recruiting
  • Resectable Gastric and Gastroesophageal Junction Adenocarcinoma
  • Oslo, Norway
  • +3 more
Mar 11, 2021

NIPD on cffDNA for Triplet Repeat Diseases

Active, not recruiting
  • Myotonic Dystrophy 1
  • +2 more
  • Non invasive prenatal diagnosis
  • Montpellier, France
    CHU Montpellier
Jan 4, 2021

Metastatic Gastric Cancer Trial in Guangzhou (Irinotecan, Oxaliplatin, 5-fluorouracil)

Recruiting
  • Metastatic Gastric Cancer
  • Guangzhou, Guangdong, China
    The Sixth Affiliated Hospital of Sun Yat-sen University
Jul 13, 2021

Stroke Trial in Tübingen (Negative peak triggered 100 Hz triplet burst TMS, 1 Hz rTMS)

Recruiting
  • Stroke
  • Negative peak triggered 100 Hz triplet burst TMS
  • 1 Hz rTMS
  • Tübingen, Baden-Württemberg, Germany
    University Hospital Tübingen, Department for Neurology and Strok
Aug 10, 2021

Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Non Invasive Prenatal Diagnosis Trial in France (Non invasive prenatal diagnosis)

Completed
  • Non Invasive Prenatal Diagnosis
  • Non invasive prenatal diagnosis
  • Bordeaux, France
  • +7 more
Dec 29, 2020

Advanced Cancers Trial in Houston (Crizotinib (Xalkori), Pazopanib, Pemetrexed)

Terminated
  • Advanced Cancers
  • Crizotinib (Xalkori)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 3, 2021

Metastatic Colorectal Cancer Trial in Italy (Panitumumab, Irinotecan, Oxaliplatin)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Milan, Italy
  • +3 more
Oct 5, 2021

Ovarian Cancer Trial in Denmark, Finland, Norway (Niraparib, Bevacizumab, TSR042)

Withdrawn
  • Ovarian Cancer
  • Copenhagen, Sjaelland, Denmark
  • +7 more
Jul 9, 2021

Gastric Adenocarcinoma, Esophagus Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in France

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Amiens, France
  • +20 more
Jul 26, 2022

Malignant Pleural Mesothelioma, Solid Tumors Trial in United States (pemetrexed, cisplatin and CBP501, pemetrexed and cisplatin,

Completed
Has Results
  • Malignant Pleural Mesothelioma
  • Solid Tumors
  • pemetrexed, cisplatin and CBP501
  • +2 more
  • Scottsdale, Arizona
  • +11 more
Jun 30, 2021

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Carfilzomib, Dexamethasone, Pomalidomide)

Active, not recruiting
  • Relapsed or Refractory Multiple Myeloma
  • Birmingham, Alabama
  • +45 more
Dec 6, 2022

Prostate Cancer Trial in Chicago (Docetaxel, ADT, Abiraterone)

Not yet recruiting
  • Prostate Cancer
  • Chicago, Illinois
    Northwestern University
Sep 27, 2023